Figure 1.
Boxplots of serum CK 18 levels in relation with steatosis, inflammation, and fibrosis in in CHB patients.
Notes: (A) No differences across grades of steatosis (P>0.05); (B) significant differences between significant and no significant inflammation (P<0.05); (C) significant differences between significant and no significant fibrosis (P<0.05).